Your Account
close button

Use our patient tools for secure, convenient, 24/7 access. Learn more


This facility is a member of

Connect with us:

Prostate Cancer

Androgen Receptor Modulation: Phase II Randomized Study of MK-2206-Bicalutamide Combination in Patients with Rising PSA at High Risk of Progression after Primary Therapy [ECOG 2809]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.